CAMP
CAMP4 THERAPEUTICS CORPORATION
3.70$
-10.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -84.9% | -45.5% | +0.0% | -28.7% | +266.5% | -19.8% | -18.3% | +68.5% | +36.4% | -10.5% | -11.4% | |
| – | -76.0% | -63.0% | +0.0% | -62.8% | +1,106.1% | -22.2% | -20.5% | +89.1% | +46.8% | -10.4% | -11.9% | |
| – | -0.5% | -67.2% | +0.0% | -79.9% | +2,433.2% | -23.0% | -20.8% | +92.7% | +45.5% | -9.4% | -12.2% | |
| – | -0.5% | -67.2% | +0.0% | -79.9% | +2,433.2% | -23.0% | -20.8% | +92.7% | +45.5% | -9.4% | -12.2% | |
| – | -99.4% | – | – | +221.2% | -90.3% | -1.9% | +0.0% | +0.0% | +46.2% | – | – | |
| – | +14.2% | – | – | – | – | – | – | – | – | – | – | |
| – | -78.4% | – | – | – | – | – | – | – | – | – | – | |
| – | -5.1% | – | – | – | – | – | – | – | – | – | – | |
| – | -49.4% | -91.7% | +1,087.4% | +1.9% | -91.6% | -26.1% | +0.8% | +145.6% | +152.8% | +6.3% | +26.2% | |
| – | -91.8% | -0.3% | +0.0% | +51.9% | -18.9% | -32.9% | +13.9% | +7.7% | +96.3% | +7.2% | +15.1% | |
| – | -1.9% | -28.7% | -8.6% | -0.4% | -0.1% | +0.9% | +1.9% | +2.5% | -91.2% | +34.3% | +108.9% | |
| – | +1.1% | -96.9% | +0.0% | +165.1% | -68.8% | +15.5% | -14.5% | +0.0% | -84.8% | +374.2% | +26.7% | |
| – | -1,271.2% | – | -1,078.6% | – | – | -18.3% | -22.5% | +46.7% | -18.7% | -35.2% | -102.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -47.3% | -37.8% | +60.9% | +0.0% | +0.0% | +0.0% | +3.4% | +0.0% | +157.5% | +11.6% | +0.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.